Last update 07 Mar 2025
NuBiyota LLC

NuBiyota LLC

Private Company|
2013|
New Jersey, United States
|
www.nubiyota.com

Overview

Tags

Neoplasms
Other Diseases
Nervous System Diseases
Live biotherapeutic products

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Nervous System Diseases1
Neoplasms1
Infectious Diseases1
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Live biotherapeutic products3

Related

3
Drugs associated with NuBiyota LLC
MET-4
Target-
Mechanism
Bacteria replacements [+1]
Active Org.
NuBiyota LLCNuBiyota LLC
Originator Org.
NuBiyota LLCNuBiyota LLC
Active Indication
Advanced Malignant Solid Neoplasm [+4]
Inactive Indication
Advanced Head and Neck Squamous Cell Carcinoma
Drug Highest PhasePhase 2/3
First Approval Ctry. / Loc.-
First Approval Date-
MET-3
Target-
Mechanism
Bacteria replacements [+1]
Active Org.
NuBiyota LLCNuBiyota LLC
Originator Org.
NuBiyota LLCNuBiyota LLC
Active Indication
Hypertriglyceridemia
Inactive Indication
Obesity, Metabolically Benign
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
MET-2
Target-
Mechanism
Bacteria replacements [+1]
Active Org.
NuBiyota LLCNuBiyota LLC
Originator Org.
NuBiyota LLCNuBiyota LLC
Active Indication
Anxiety Disorders [+2]
Inactive Indication
Colitis, Ulcerative [+2]
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
9
Clinical Trials associated with NuBiyota LLC
NCT05743777
/ WithdrawnPhase 2IIT
A Phase II Study of PembROlizumab With or Without Microbial EcOsystem ThErapeutic 4 (MET4) in Advanced Head and Neck Squamous Cell Carcinoma
NCT04602715
/ Unknown statusPhase 2
The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression
NCT04507971
/ Unknown statusPhase 1
Effects of MET-3 and MET-5 on Gut Microbiome and Metabolic Function in Men and Women With Hypertriglyceridemia
100 Clinical Results associated with NuBiyota LLC
Login to view more data
0 Patents (Medical) associated with NuBiyota LLC
Login to view more data
100 Deals associated with NuBiyota LLC
Login to view more data
100 Translational Medicine associated with NuBiyota LLC
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 09 Mar 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2
2
1
Phase 3
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
MET-4
Advanced Malignant Solid Neoplasm
More
Phase 2/3
MET-2
Anxiety Disorders
More
Phase 2
MET-3
Hypertriglyceridemia
More
Phase 2
TAK-039
Clostridium Infections
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free